Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
About the role This is a rare opportunity to make a significant impact inside a Fortune 500 company in the mid of a strategic transformation. The Adecco Group is leading the global movement around the future
Work Model: This role can be performed remotely from an approved location, with flexibility based on business needs and applicable requirements. SUMMARY We are seeking an experienced key accounts manager to join our Portescap / Micro-Motion